159 related articles for article (PubMed ID: 11880373)
1. Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor.
Ignjatovic T; Tan F; Brovkovych V; Skidgel RA; Erdös EG
J Biol Chem; 2002 May; 277(19):16847-52. PubMed ID: 11880373
[TBL] [Abstract][Full Text] [Related]
2. Activation of bradykinin B1 receptor by ACE inhibitors.
Ignjatovic T; Tan F; Brovkovych V; Skidgel RA; Erdös EG
Int Immunopharmacol; 2002 Dec; 2(13-14):1787-93. PubMed ID: 12489793
[TBL] [Abstract][Full Text] [Related]
3. Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands.
Ignjatovic T; Stanisavljevic S; Brovkovych V; Skidgel RA; Erdös EG
Mol Pharmacol; 2004 Nov; 66(5):1310-6. PubMed ID: 15304551
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin.
Marcic BM; Erdös EG
J Pharmacol Exp Ther; 2000 Aug; 294(2):605-12. PubMed ID: 10900238
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells.
Stanisavljevic S; Ignjatovic T; Deddish PA; Brovkovych V; Zhang K; Erdös EG; Skidgel RA
J Pharmacol Exp Ther; 2006 Mar; 316(3):1153-8. PubMed ID: 16282523
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of bradykinin and resensitization of its B2 receptor.
Marcic B; Deddish PA; Jackman HL; Erdös EG
Hypertension; 1999 Mar; 33(3):835-43. PubMed ID: 10082496
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.
Minshall RD; Tan F; Nakamura F; Rabito SF; Becker RP; Marcic B; Erdös EG
Circ Res; 1997 Nov; 81(5):848-56. PubMed ID: 9351459
[TBL] [Abstract][Full Text] [Related]
8. Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors.
Marcic B; Deddish PA; Skidgel RA; Erdös EG; Minshall RD; Tan F
J Biol Chem; 2000 May; 275(21):16110-8. PubMed ID: 10748135
[TBL] [Abstract][Full Text] [Related]
9. Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor.
Deddish PA; Marcic BM; Tan F; Jackman HL; Chen Z; Erdös EG
Hypertension; 2002 Feb; 39(2 Pt 2):619-23. PubMed ID: 11882619
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
Nikolaidis LA; Doverspike A; Huerbin R; Hentosz T; Shannon RP
Circulation; 2002 Jun; 105(23):2785-90. PubMed ID: 12057995
[TBL] [Abstract][Full Text] [Related]
11. Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors.
Persson K; Andersson RG
J Cardiovasc Pharmacol; 1998 Feb; 31(2):306-13. PubMed ID: 9475274
[TBL] [Abstract][Full Text] [Related]
12. [ACE inhibitors--activators of kinin receptors].
Kugaevskaia EV; Eliseeva IuE
Biomed Khim; 2011; 57(3):282-99. PubMed ID: 21863742
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
[TBL] [Abstract][Full Text] [Related]
14. Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor?
Fortin JP; Gobeil F; Adam A; Regoli D; Marceau F
Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H277-82. PubMed ID: 12649080
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms involved in the angiotensin II-independent hypotensive action of ACE inhibitors.
Hecker M; Pörsti I; Busse R
Braz J Med Biol Res; 1994 Aug; 27(8):1917-21. PubMed ID: 7749381
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?
Tom B; Dendorfer A; Danser AH
Int J Biochem Cell Biol; 2003 Jun; 35(6):792-801. PubMed ID: 12676166
[TBL] [Abstract][Full Text] [Related]
17. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors.
Scharfstein J; Schmitz V; Morandi V; Capella MM; Lima AP; Morrot A; Juliano L; Müller-Esterl W
J Exp Med; 2000 Nov; 192(9):1289-300. PubMed ID: 11067878
[TBL] [Abstract][Full Text] [Related]
18. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells.
Busse R; Lamontagne D
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):126-9. PubMed ID: 1663586
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells.
Benzing T; Fleming I; Blaukat A; Müller-Esterl W; Busse R
Circulation; 1999 Apr; 99(15):2034-40. PubMed ID: 10209009
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: role of bradykinin generation during ACE inhibition.
Mombouli JV; Vanhoutte PM
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S74-82. PubMed ID: 1282634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
